Day One Biopharmaceuticals Inc (DAWN)
13.72
+0.38
(+2.85%)
USD |
NASDAQ |
Nov 22, 16:00
15.14
+1.42
(+10.35%)
After-Hours: 20:00
Day One Biopharmaceuticals Gross Profit Margin (Quarterly): 98.30% for Sept. 30, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 98.30% |
| Date | Value |
|---|---|
| June 30, 2024 | 91.37% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
91.37%
Minimum
Jun 2024
98.30%
Maximum
Sep 2024
94.84%
Average
94.84%
Median
Gross Profit Margin (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -- |
| Electromed Inc | 78.34% |
| Xtant Medical Holdings Inc | 58.37% |
| Myomo Inc | 75.43% |
| Catheter Precision Inc | 89.58% |
Gross Profit Margin (Quarterly) Related Metrics
| Profit Margin (Quarterly) | 39.50% |
| Operating Margin (Quarterly) | 31.61% |